About 150mg Reliance Trastuzumab Injection
Experience the latest advancement in anticancer therapy with the elite 150mg Reliance Trastuzumab Injection (Brand: Ontramab)-a bargain for those seeking pivotal treatment for HER2-positive breast and gastric cancers. This redoubtable monoclonal antibody, originating from r-DNA technology, is delivered as a lyophilised powder in a sturdy glass vial. Redeem the therapeutic value through sterile water reconstitution and intravenous infusion, under medical supervision. Prescription required. This medicine is suitable for adults, ensuring high quality and safety. Store below 25C, adhering strictly to storage guidelines for optimal efficacy. Each pack contains one 150mg vial, made in India.
Advanced Therapy for Cancer Care
The 150mg Reliance Trastuzumab Injection is a monoclonal antibody administered via intravenous infusion. Its primary application is in the treatment of HER2-positive breast and stomach cancers, providing critical support in oncology protocols. Suitable for adults, its formulation allows precise dosage as per your doctor's guidance. The lyophilised powder is to be reconstituted with sterile water before use. Ontramab's pivotal area of application is in hospital settings, clinics, and cancer specialty centers under strict medical supervision.
Certifications, Packing, and Reliable Supply
Reliance Trastuzumab Injection is processed adhering to international quality certifications, ensuring safety and efficacy. Packing & dispatch are managed with careful attention, utilizing glass vials in secure packaging to maintain stability during shipment. Customers can request samples under the supplier's sample policy. With robust supply abilities, the product is shipped efficiently across India and internationally. Order processing is streamlined for prompt delivery, ensuring that each order receives precise attention from placement to dispatch.
FAQ's of 150mg Reliance Trastuzumab Injection:
Q: How should the 150mg Reliance Trastuzumab Injection be administered?
A: This injection must be given as an intravenous infusion only, after proper dilution with sterile water and strictly following the doctor's prescription.
Q: What is the specific usage of Ontramab Trastuzumab Injection?
A: Ontramab is specifically indicated for adults diagnosed with HER2-positive breast or stomach (gastric) cancers as part of an antineoplastic treatment regimen.
Q: When is it necessary to use this injection?
A: Use of this injection is warranted when a patient has been diagnosed with HER2-positive cancer and a qualified physician prescribes Trastuzumab as part of the cancer therapy.
Q: Where can the injection be appropriately administered?
A: The injection is administered in healthcare settings such as hospitals or specialist cancer treatment centers, under the supervision of trained medical professionals.
Q: What is the process for reconstituting this lyophilised powder?
A: The powder in the glass vial should be reconstituted with sterile water for injection, following provided guidelines, just before intravenous infusion.
Q: What are the benefits of using Reliance Trastuzumab Injection?
A: This redoubtable therapy offers targeted action against HER2-positive cancer cells, potentially improving treatment outcomes and patient survival rates within its therapeutic class.